(AIMD)
NASDAQ: AIMD
· Real-Time Price · USD
0.48
-0.03 (-5.42%)
At close: Jun 26, 2025, 3:59 PM
-5.42% (1D)
| Bid | 0.48 |
| Market Cap | 9.98M |
| AUM | - |
| NAV | - |
| EPS (ttm) | -1.20 |
| PE Ratio (ttm) | -0.40 |
| Shares Out | 20.96M |
| Inception Date | Invalid Date |
| Ask | 0.53 |
| Volume | 413.14K |
| Open | 0.49 |
| Previous Close | 0.51 |
| Day's Range | 0.48 - 0.50 |
| 52-Week Range | 0.40 - 1.07 |
| Holdings | - |
| Expense Ratio | undefined% |
About AIMD
A detailed description of the company is not yet available.
Asset Class undefined
Ticker Symbol AIMD
Inception Date Invalid Date
Provider undefined
Website Fund Home Page
Exchange NASDAQ
10 months ago
+8.06%
Ainos shares are trading higher after the company ...
Unlock content with
Pro Subscription
10 months ago
+1.2%
Ainos shares are trading higher after the company announced that it has obtained exclusive licenses for a total of 10 invention patents and patent applications from Taiwan Carbon Nano Technology.
2 weeks ago · accessnewswire.com
Ainos Issues Mid-Year Update: Reaching Strategic Inflection in SmellTech and ImmunotherapyAI Nose Platform Advances Toward Scaled Pilot Programs Across Healthcare, Robotics, and Industrials VELDONA® Oral Interferon Receives Approval to Begin Human Trials in Taiwan SAN DIEGO, CA / ACCESS Ne...
1 month ago · accessnewswire.com
Ainos AI Nose Improves Accuracy in Hygiene Monitoring To 85% from 80%Accelerating Toward Commercial Rollout as AI Nose Solves Critical Gaps in Elder Care SAN DIEGO, CA / ACCESS Newswire / May 29, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos"), a leader in AI-...
